NCT03200171View on ClinicalTrials.gov

Effect of DAAs on Behavior of HCC in HCV Patients

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

February 10, 2018

Primary Completion Date

June 19, 2021

Study Completion Date

July 19, 2021

Conditions
Carcinoma, HepatocellularHepatitis C
Trial Locations (3)

11651

MOHAMED Alboraie, Cairo

Unknown

Helwan University, Cairo

National Hepatology and Tropical Medicine Research Institute, Cairo

All Listed Sponsors
collaborator

Helwan University

OTHER

collaborator

Cairo University

OTHER

collaborator

Ain Shams University

OTHER

lead

Al-Azhar University

OTHER

NCT03200171 - Effect of DAAs on Behavior of HCC in HCV Patients | Biotech Hunter | Biotech Hunter